Onconetix Inc (ONCO) Live Share Price, Invest From India

Onconetix Inc Stock Performance

as on May 2, 2026 at 6:59 am IST

Day's Low
Day's High
$0.62
Day's Price Range
$0.67
$0.64
3.13%
Downside
4.69%
Upside
52 Week's Low
52 Week's High
$0.57
52-Week Price Range
$74.29
$0.64
10.75%
Downside
11507.81%
Upside

Onconetix Inc share price movements today

Previous Close: $0.69
Open: $0.66
Volume: 1.0M
Day's Low - High: $0.62 - $0.67
52 Week Low - High: $0.57 - $74.29

Onconetix Inc Historical Returns

1 Month Return: -58.22 %
3 Month Return: -90.99 %
1 Year Return: -97.86 %
3 Year Return: 0 %
5 Year Return: 0 %

Onconetix Inc Stock Fundamentals & Key Indicators

Check Onconetix Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$8.0M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-6.3M

Revenue (TTM)

815.4K

Profit Margin

0.00%

Return On Equity TTM

-115.46%

Onconetix Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Onconetix Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Onconetix Inc	SELL	$8.0M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$41.3B	110.54%	77.57	12.55%
Vertex Pharmaceuticals Inc	BUY	$108.7B	94.28%	27.93	32.94%
BeiGene, Ltd.	NA	$32.7B	NA	118.49	5.37%
Regeneron Pharmaceuticals Inc	BUY	$74.1B	45.73%	17.27	29.65%

Stock Returns calculator for Onconetix Inc Stock including INR - Dollar returns

The Onconetix Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Onconetix Inc investment value today

Current value as on today

₹2,421

Returns

-₹97,579

(-97.58%)

Returns from Onconetix Inc Stock

-₹97,842 (-97.84%)

Dollar Impact

₹263 (+0.26%)

Analyst Recommendation on Onconetix Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Onconetix Inc. Average target price of $9

Onconetix Inc Share Price Target

Get share price movements and forecasts by analysts on Onconetix Inc.

What analysts predicted

92.89%UPSIDE

Target Price

Current Price

$0.64

Analyzed by

6 Analysts

Target

$9.00

Onconetix Inc target price $9, a slight upside of 92.89% compared to current price of $0.64. According to 6 analysts rating.

Onconetix Inc Stock’s Investor Sentiment and Interest

Investment in Onconetix Inc Shares on INDmoney has grown by 540.00% over the past 30 days, indicating increased transactional activity.

Time period: April 2, 2026 to May 2, 2026

Change:540.00% versus previous 30 day period

Search interest for Onconetix Inc Stock has increased by 219% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 2, 2026 to May 2, 2026

Change:219% versus previous 30 day period

Onconetix Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	0	0	0	0	0	0	0	0	0
Gross Profit	0	-	0	0	0	0	0	0	0	0
Operating Income	-4	-7	-11	-13	-2	-1	-12	-1	-2	-1
EBITDA	-5	-	-10	-13	-3	-	-8	-2	-8	-1
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-5	-22	-11	-14	-3	-30	-8	-2	-8	5
Income Tax Expense	0	-	0	0	0	-	0	-	-	0
Net Income	-5	-22	-11	-14	-3	-29	-8	-2	-8	5
Net Profit Margin	0.00%	-38229.49%	-1587.39%	-2029.76%	-940.72%	-4134.74%	-8408.82%	-2227.77%	-2892.70%	1867.51%

Onconetix Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	0	2	0
Gross Profit	0	0	0	-1	1	0
Operating Income	-1	-3	-13	-36	-56	-6
EBITDA	-1	-3	-13	-36	-57	-6
Interest Expense	-	-	-	0	1	0
Depreciation	0	0	0	0	0	0
Income Before Tax	-1	-3	-13	-37	-59	-14
Income Tax Expense	0	0	0	0	-1	0
Net Income	-1	-3	-13	-37	-58	-14
Net Profit Margin	0.00%	0.00%	0.00%	-63986.48%	-2325.21%	-1720.98%

Onconetix Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-22	-11	-14	-3	-29	-8	-2	-8	5
Operating Cash Flow	-4	-5	-3	-1	0	-1	-1	-3	-3
Investing Cash Flow	-	0	0	0	-	0	-	-	-
Financing Cash Flow	-	5	0	0	1	2	0	4	6
Change in Cash	-3	0	-3	0	0	0	-1	0	4

Onconetix Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-1	-3	-13	-37	-58	-14
Operating Cash Flow	-1	-2	-8	-13	-10	-9
Investing Cash Flow	0	0	0	-8	0	-
Financing Cash Flow	-	0	32	1	6	14
Change in Cash	-1	-2	23	-21	-3	4

Insights on Onconetix Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, ONCO stock has moved up by 8.1%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 15.8% return, outperforming this stock by 113.7%
NO EFFECT
Against Peers
In the last 3 years, ONCONETIX INC has experienced a drawdown of -39.5%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 27.3%

About Onconetix Inc

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.

Organisation	Onconetix Inc
Headquarters	201 East Fifth Street, Cincinnati, OH, United States, 45202
Industry	Biotechnology
CEO	Mr. David Allan White C.A., C.P.A., ICD.D
E-voting on shares	Click here to vote

Key Management of Onconetix Inc

Name	Title
Ms. Karina M. Fedasz	Interim Chief Financial Officer
Mr. David Allan White C.A., C.P.A., ICD.D	Chief Executive Officer
Mr. Andrew D. Skibo Ph.D.	Global Head of Biologics Operations
Dr. Brian Price Ph.D.	Head of Technology Strategy
Mr. Theodore Scott Yoho	Head of Business Development
Dr. Ali I. Fattom Ph.D.	Head of Science & Discovery
Dr. Jay Newmark M.B.A., M.D.	Chief Medical Officer

FAQs

What is Onconetix Inc share price today?

Onconetix Inc share price today is $0.64 as on May 2, 2026 at 1:29 am IST at the close of the market. Onconetix Inc share today touched a day high of $0.67 and a low of $0.62.

What is the 52 week high and 52 week low for Onconetix Inc share?

Onconetix Inc share touched a 52 week high of $74.29 on May 14, 2025 and a 52 week low of $0.57 on April 24, 2026. Onconetix Inc stock price today i.e. May 2, 2026 at 1:29 am IST is closed at $0.64,which is 99.14% down from its 52 week high and 12.04% up from its 52 week low.

What is Onconetix Inc's market capitalisation today?

Onconetix Inc market capitalisation is $0.00T as on May 2, 2026 at 1:29 am IST.

How to invest in Onconetix Inc Stock (ONCO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Onconetix Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Onconetix Inc Shares that will get you 2.3438 shares as per Onconetix Inc share price of $0.64 per share as on May 2, 2026 at 1:29 am IST.

What is the minimum amount required to buy Onconetix Inc Stock (ONCO) from India?

Indian investors can start investing in Onconetix Inc (ONCO) shares with as little as ₹94.91 or $1 (as of May 2, 2026 at 6:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.10 in Onconetix Inc stock (as per the Rupee-Dollar exchange rate as on May 2, 2026 at 6:41 pm IST). Based on Onconetix Inc share’s latest price of $0.64 as on May 2, 2026 at 1:29 am IST, you will get 15.6250 shares of Onconetix Inc. Learn more about fractional shares .